Behavioral effects of endogenous or exogenous (mu, delta) opioid peptides: relation with DA mesolimbic pathways.
Calenco-Choukroun
G
G
Département de Chimie Organique, U266 INSERM, Paris, France.
Daugé
V
V
Féger
J
J
Roques
B P
BP
D000818:Animals; D004151:Dipeptides / Q000494:pharmacology; D004298:Dopamine / Q000502:physiology*; D004723:Endorphins / Q000494:pharmacology / Q000502:physiology*; D020875:Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; D004745:Enkephalins / Q000494:pharmacology; D006892:Hydroxydopamines / Q000494:pharmacology; D008032:Limbic System / Q000187:drug effects / Q000502:physiology; D008297:Male; D009043:Motor Activity / Q000187:drug effects / Q000502:physiology*; D016627:Oxidopamine; D051381:Rats; D011919:Rats, Inbred Strains; D011957:Receptors, Opioid / Q000187:drug effects / Q000502:physiology; D017465:Receptors, Opioid, delta; D017450:Receptors, Opioid, mu
D004151:Dipeptides; D004723:Endorphins; D004745:Enkephalins; D006892:Hydroxydopamines; D011957:Receptors, Opioid; D017465:Receptors, Opioid, delta; D017450:Receptors, Opioid, mu; D020875:Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; C042591:kelatorphan; D016627:Oxidopamine; D004298:Dopamine